Captopril

Hometown of Ithaca, NY, for the past two years running, an experience that I have really enjoyed. The play is very layed back, which meant that I showed up at Oberlin with knowledge of stack play, and the rudiments of zone. I was fairly athletic in highschool, having played soccer and ice hockey for most of my life, and I could throw a respectable enough forehand that I was accepted into the horsecow family more or less from the start. 2. What position do you play want to play, etc? I'm rather short in, so I'm not sure if I have much hope of being a long. This semester I've seen sure signs that my elders wish to groom me as a handler. However, I much prefer the feeling of busting deep, with a defender struggling behind me, and soaring up to catch the disc over someone with a good few inches on me in height, hanging back and making dump cuts that are usually looked off. I have to admit that the feeling of putting a scoring, buttery OI forehand huck is a hell of a rush, but in general, my throws aren't consistent enough to make handling very satisfactory. 3. What is your favorite alumni Ultimate story? As for alumni stories, I've heard a lot of good ones. One that particularly sticks in my mind is the one where Adam Marvel catches a disc in the endzone, pulls a sharpie out of his shorts, signs the disc, and hands it to his defender. That's a lot of sauce. Never a week goes by where there the upperclassman don't tell us young'uns a good alumni story or three. [Note: This was not actually Marvel, but a UCSD player at Ultimax 2k2. -- Ed.] 4. What are you looking forward to this year and next? Anyway, I hope to finish off the year with a couple of money plays at sectionals and regionals, skying anyone significantly taller than me or any sort of sick layout-d would make me more than content. This summer I planning to improve my throws enough that I can enjoy handling a little more, but for a long term goal I. BCS is currently not employed in Japan, which, however, should be used as a risk factor when dissolution test is expanded to "Biowaiver" for major changes in formulation and manufacturing and even for generic products, when the disadvantages of dissolution tests are considered. By the combination use of dissolution test and BCS, significant bio-inequivalence problems will be avoided, leading to the reduction of patient's risk Immediate application of dissolution test for all classes of drugs is risky. Not what you'd expect to hear from a drug company. The Merck Patient Assistance Program has provided Merck medicines free to those who can't afford them for nearly 50 years. To find out if you're eligible, call 1- 800 - 727 - 5400 or visit merck. Elite pharmaceuticals inc eli ; elite pharmaceuticals, inc, a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled release products. Although it is generally believed that ACE inhibitors are similar, not all prescribers agree with this viewpoint. The HOPE trial provided unique data showing benefit for the use of ramipril in reducing cardiovascular complications in patients 55 years of age or older and who are at risk for these complications, but who do not need an ACE inhibitor for heart failure, uncontrolled hypertension, diabetes, or renal disease. Therefore, ramipril was added in the Formulary for this narrow indication. Captopril, enalapril, and lisinopril are the ACE inhibitors that have been and remain listed in the Formulary. Captopril and enalapril are often used in pediatric patients. Lisinopril is the preferred once-daily ACE inhibitor listed. Lisinopril is available as a generic and is an inexpensive option in the category. In the outpatient setting, patients will pay less for lisinopril than other once-daily ACE inhibitors, whether they are insured and pay a co-pay or if they pay cash for their prescriptions. The remaining 6 oral ACE inhibitors on the market benazepril, fosinopril, moexepril, perindopril, quinapril, trandolapril ; will no longer be available through a nonformulary request, effective October 1, 2003. When these drugs are prescribed in September, prescribers will be contacted and alerted to this pending change. Pharmacists will be prepared to offer an approximate equivalent dosage of lisinopril. A dosage equivalent chart is available on the Shands intranet at : intranet.shands pharm ACEI Convert . Bosentan is an endothelin antagonist that is used as an oral alternative to intravenous epoprostenol Flolan ; for the treatment of pulmonary hypertension. It was added in the Formulary in October 2002. Recently, Shands at UF was notified that the hospital can no longer stock this drug. The manufacturer stated that the FDA mandated that bosentan be limited to only a restricted distribution program because of concerns about hepatotoxicity. Since bosentan can no longer be stocked, it was deleted from the Formulary and designated a "high-priority" nonformulary drug. Patients will have to provide their own supply for use during their hospitalization. Methyltestosterone tablets are not used in the inpatient setting. There has been no use of methyltestosterone in the past 2 years. Therefore, it was deleted from the Formulary Tocainide is an oral, local anesthetictype antiarrhythmic agent similar to mexiletine. It has been used only to treat life-threatening arrhythmias. The drug does cross the placentas of rats and rabbits in late gestation 1 and diltiazem. When.available, are.required.if.a.provider termines.that.there.is.a.medical. need.for.a and.equivalent, .a.request.for.coverage.may.be. made products.with plex.pharmacokinetics, .dosage.forms!

43. Kober L, Torp-Pedersen C, Carlsen JE, et al. for Trandolapril Cardiac Evaluation TRACE ; Study Group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995; 333: 1670-1676. Cohn JN, Tognoni G. A randomized trial of the angiotensinreceptor blocker valsartan in chronic heart failure. N Engl J Med. 2001; 345: 1667-1675. Pitt B, Zannad F, Remme WJ, et al. for Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone of morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999; 341: 709-717. Braunwald E, Antman EM, Beasley JW, et al. ACC AHA 2002 guideline update for the management of patients with unstable and angina and non-ST-segment evaluation myocardial infarction. J Coll Cardiol. 2002; 40: 1366-1374. -Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA. 1982; 247: 1707-14. Hager WD, Davis BR, Reba A, et al., for the Survival and Ventricular Enlargement SAVE ; Investigators. Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: the SAVE Study Experience. Heart J. 1998; 135: 406-413. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial. Lancet. 2001; 357: 1385-1390. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003; 348: 1309-1321. Black HR, Elliott WJ, Grandits G, et al. Principle results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points CONVINCE ; trial. JAMA. 2003; 289: 2073-2082. National Kidney Foundation Guideline. K DOQI clinical practice guidelines for chronic kidney disease: Kidney Disease Outcome Quality Initiative. J Kidney Dis. 2002; 39 suppl2 ; : S1-S246. 53. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ. 1998; 317: 713-720. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med. 1993; 329: 1456-1462. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345: 861-869. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001; 345: 851-860. The GISEN. Gruppo Italiano di Studi Epidemiologici in Nefologia ; Group. Randomized placebo controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997; 349: 1857-1863. PROGRESS Collaborative Group. Randomized trial of perindopril based blood pressure lowering regimen among 6, 105 individuals with previous stroke or transient ischemic attack. Lancet. 2001; 358: 1033-1041. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157: 2413-2446 and doxazosin. Journal of the medical association of thailand chotmaihet thangphaet department of neuro-psychiatry, pramongkutklao army medical college, bangkok 10400, thailand.

Buy captopril

Plan assets will be shared among Plan participants and beneficiaries according to federal regulations issued under the Employee Retirement Income Security Act of 1974, as amended, in the following order: 1. Certain annuities to the extent guaranteed by the PBGC ; that participants have been receiving or could have been receiving for at least five years prior to Plan termination. 2. Other vested benefits to the extent guaranteed by the PBGC ; for participants and beneficiaries not included above who have benefits guaranteed under the Plan by the PBGC. 3. Other vested benefits to the extent not provided for above ; for all participants and beneficiaries who have met the vesting requirements. 4. All other benefits that have not been provided for above. Your pension benefits under the Plan are insured by the PBGC. If the Plan terminates without enough money to pay all benefits, the PBGC will step in to pay pension benefits. Most people receive all of the pension benefits they would have received under their plan, but some people may lose certain benefits. The PBGC guarantee generally covers Normal and early retirement benefits. Disability benefits if you become disabled before the Plan terminates. Certain benefits for your survivors. The PBGC guarantee generally does not cover Benefits greater than the maximum guaranteed amount set by law for the year in which the Plan terminates. Some or all of benefit increases and new benefits based on Plan provisions that have been in place for fewer than five years at the time the Plan terminates. Benefits that are not vested because you have not worked long enough for the Company. Benefits for which you have not met all of the requirements at the time the Plan terminates. Certain early retirement payments such as supplemental benefits that stop when you become eligible for Social Security ; that result in an early retirement monthly benefit greater than your monthly benefit at the Plan's normal retirement age. Nonpension benefits, such as health insurance, life insurance, certain death benefits, vacation pay, and severance pay. Even if certain of your benefits are not guaranteed, you still may receive some of those benefits from the PBGC depending on how much money the Plan has and how much the PBGC collects from employers. For more information about the PBGC and the benefits it guarantees, ask the Plan Administrator or contact the PBGC's Technical Assistance Division, 1200 K Street NW, Suite 930, Washington, DC 20005-4026, or call 202-326-4000 hearing impaired at 1-800-877-8339 and ask to be connected to 202-326-4000 ; . Additional information about the PBGC's pension insurance program is available through the PBGC web site : pbgc.gov and mesylate. Secondly, medications to treat blood pressure have side effects all of them to some degree.

Captopril online

31 allylmercaptocaptopril: a new antihypertensive drug and catapres.
Butalbital asa caffeine, 9 butalbital aspirin caffei, 10 butorphanol 1 mg ml vial, 12 butorphanol 10 mg ml spray, 12 butorphanol 2 mg ml syringe, 12 butorphanol 2 mg ml vial, 12 butorphanol tartrat 1 mg ml, 12 butorphanol tartrat 2 mg ml, 12 CADUET 10 MG 10 TABLET, 49 CADUET 10 MG 20 TABLET, 49 CADUET 10 MG 40 TABLET, 49 CADUET 10 MG 80 TABLET, 49 CADUET 2.5 MG 10 MG TABLET, 49 CADUET 2.5 MG 20 MG TABLET, 49 CADUET 2.5 MG 40 MG TABLET, 49 CADUET 5 MG 10 TABLET, 49 CADUET 5 MG 20 TABLET, 49 CADUET 5 MG 40 TABLET, 49 CADUET 5 MG 80 TABLET, 49 CAFCIT, 5 CAFERGOT, 87 CALAN, 47 CALAN SR, 47 CALCIBIND, 81 calcitriol, 116 CALCIUM CHANNEL BLOCKERS, 47 cal-nate, 93 camila, 53 CAMPRAL, 107 CANASA, 81 CANCIDAS, 29 CANTIL, 110 CAPEX, 65 CAPITAL CODEINE, 12 CAPITROL, 65 CAPOTEN, 33 CAPOZIDE, 33 captopril, 33 captopril hydrochlorothia, 33 CARAC, 65 CARAFATE 1 GM TABLET, 110 CARAFATE 1 GM 10 SUSPENSI, 110 carbamazepine, 23 CARBATROL, 23 carbaxefed rf, 58 carbic ds, 58 carbidopa levodopa, 40, 41 carbidopa levodopa cr, 40 carbidopa levodopa er, 40 carbidopa levodopa sr, 41!

Write to them in care of this newspaper or e-mail them via their web site: site 2004 king features syndicate, inc captopril test captopril what do phentermine capsules or tablets do and cefaclor.

In recent years, there has been an increase in reports of club drugs used to commit sexual assaults.

Buy captopril online

36 foil packed tablets per box and cefuroxime.

Steps to take when testing: 1 ; Wash hands with soapy water and dry them well. Do not use alcohol swabs before testing. You don't need them and it will dry the skin and cause more pain. 2 ; Insert the lancet needle ; into the lancing device used to hold the needle ; . Set the device ready to use talk to your pharmacist if you are unsure of this ; . Never use the same lancet twice; it will hurt a lot more! 3 ; Take out a test strip of the box of test strips that came with your meter. Check that the strips are not out of date! 4 ; Insert the test strip into your meter. 5 ; Place the lancet device near the side of your finger, making sure to use a different finger each time. Prick the skin and you should see a little speck of blood. 6 ; Apply pressure to the finger and point it to the ground. Take the strip and place it near the speck of blood. The strip will pull that blood inside and then will give you a reading on the display. 7 ; You are finished! Remember to write down every reading you take to see how are you doing week by week. Sidized while government programs provide low-income people with free drugs. If these patients were told to take Q10 supplements with their statins, many would be unwilling to do so unable to bear the extra expense. On the flip side, many statin drugs are not taken because of side effects that Q10, if taken, might alleviate. If so, drug companies may be shortchanging themselves in the long run by not recommending Q10 supplementation. What do the other countries who recommend Q10 supplement with statins see in the science? Has this been adequately researched? Drug companies and the FDA should look for a definitive answer and citalopram.
Increase triglyceride and low-density lipoprotein cholesterol levels and reduce high-density lipoprotein cholesterol levels. -Blockers may also impair awareness of hypoglycemia and delay recovery from hypoglycemia. It is likely that selective 1-blocking agents cause less metabolic derangement compared to nonselective agents.43 In UKPDS18 glycemic control after 4 years was adversely affected by atenolol vs captopril, with average hemoglobin A1C values of 7.5%1.4% in the atenolol group and 7.0%1.4% in the captopril group. The atenolol-assigned patients also frequently required the addition of a second oral hypoglycemic medication compared with the captopril group. Carvedilol, a nonselective -blocker with -antagonist properties which theoretically improve carbohydrate metabolism ; at a dose of 25 mg d was compared to atenolol at 50 mg d. Atenolol-treated patients had a 0.3% increment in glycosylated hemoglobin over 3 months vs a 0.1% decrement for carvedilol-treated patients. Other measures of glycemic control changed directionally in a similar fashion.44 The least adverse effect on glycemic control appears to be a subclass effect of all combined - and -antagonists.45, 46 In general we favor selective 1-blockers, or, if metabolic control of diabetes is particularly problematic, carvedilol because it produces less aggravation of hyperglycemia and hyperlipidemia. Step 4--Calcium Blockers Amlodipine, nisoldipine, nifedipine and gastrointestinal transport system all 3 dihydropyridine-type calcium blockers ; , and diltiazem nondihydropyridine ; have all recently been used in large-scale clinical trials. In a placebocontrolled study Syst-Eur ; , 12 the dihydropyridine calcium antagonist nitrendipine showed a benefit in patients with type 2 diabetes mellitus. In ABCD15 nisoldipine was associated with an increase in myocardial infarction compared with enalapril. Nondihydropyridine calcium antagonists, including verapamil, appear to reduce microalbuminuria in proportion with their blood pressure reduction.47 They appear to have no effect on glycemic control or lipid levels. The nondihydropyridine calcium antagonists verapamil and diltiazem, which also lower heart rate, when used in combination with ACE inhibitors may provide additional protection to the kidneys in diabetic patients with nephropathy.48 Other Agents and Combinations In a small minority of diabetic patients with hypertension, more than 4 agents may be necessary. A second diuretic, central -antagonist, angiotensin II receptor blocker, or direct vasodilator may be used. Numerous single-pill antihypertensive drug combination preparations are available.1.

Several patients suffering from chronic headache overuse this symptomatic medication in the attempt to control their headache and chloromycetin. In the oxford study, of the 27, 442 patients who received captopril, 1, 886 died after 35 days. Lorcet before starting lorcet stopping any of your medicines and chloramphenicol and captopril. COST. ACEIs and ATRAs are expensive. Captopril has recently become generic, which has significantly reduced its cost. Benazepril Lotensin ; is the next least expensive to date. Initiate therapy with captopril for the reasons given previously, and then change to the least expensive long-acting form or to an ATRA. Despite the lack of a formal indication for benazepril in CHF, many clinicians use it at one-half the HTN dose because of the cost variable. DIFFICULTY IN SWALLOWING. For patients who have difficulty in swallowing, ramipril Altace ; may be a good choice. The capsules may be opened and sprinkled on applesauce, added to apple juice, or dissolved in 4 oz water with no change in the effectiveness of the drug. Captopril may be crushed but may have a sulfurous odor and requires bid or tid dosing.
An important element on the second floor is the development of the Main Activity Hall within the space currently used as computer training facilities rooms 208 and 210 ; . These rooms currently are separated by a solid demising wall and both have tiered flooring. This proposal recommends that the demising wall be demolished and replaced with a moveable partition with good sound insulation properties. A new floor will need to be constructed over the existing tiers; this floor will be level with the foyer floor and will be finished in manner suitable for seating both in chairs and directly on the floor. The development of the Main Activity Hall will also include the construction of four alcoves that will accommodate religious artifacts and icons for the various faith groups. There is currently a small room 108A ; with one of the training facilities that is assigned as an electrical room. If this room is not needed for building infrastructure, then it could be assigned as a larger alcove. As well, the Crying Room could be constructed in the south end of the Main Activity Hall; this room will have glazed partitions and can have a door connection with the Hall and the adjacent corridor. The glazed partition will be supplied with blinds to enable this room to be scheduled independently of the Main Activity Hall. The foyer 214K ; will not only act as the main circulation space on the floor, but also accommodate spill-over seating for the Main Activity Hall and other Centre functions such as, faith group displays, conference and workshop registration, etc. Significant changes are not proposed for this floor's foyer except to ensure that suitable electrical services are available throughout the foyer; it may also be desirable to provide several telecommunication outlets next to these electrical outlets. This floor will also accommodate the Multipurpose Room in the existing conference room room 207 ; . It is recommended that this room be reduced slightly in floor area to allow the construction of a food servery in an expanded room 202 that includes the small storage closet in 207A ; . This servery will allow food, beverages and associated dishes cutlery to be readied prior to being brought out into the Multipurpose Room or elsewhere on the floor. In order to fit ablution facilities into the existing washrooms, it is recommended that the custodial closet 204 ; be demolished and its space used for the necessary fixtures and furnishings. It likely will be necessary to shift the existing washroom doors to the opposite ends of their respective corridor walls; this will ensure not only that sufficient space will be available for the ablution facilities but also there will be as much separate as possible between the two genders. The rooms currently used as a small seminar room room 213 ; , its associated vestibules 213A and 213B ; , and a coat room 215 ; will be demolished and re-developed into the Centre's storage facilities such as, faith groups general storage, furniture storage, equipment storage, and men's and women's prayer mats and cushion storage. These storage facilities will allow the optimal functional use of the Main Activity Hall. As well, this floor area can be developed to include coat rooms for male and female visitors to the Centre and cilexetil.

Buy cheap captopril

First we were nine and now 12. What are we? Answer: a powerful statement that says Colorado Cancer Research Program's CCRP ; purpose and work as a community-based cancer research program is valuable and desired. We welcome Boulder Community Hospital, Longmont United Hospital, and Sky Ridge Medical Center -- HealthONE in joining CCRP's nine other partners who support the mission to advance the cancer research that will benefit doctors and patients today and tomorrow.

17, 2007 mouthpiece could help ease snoring cancer care might impair driving gene mutation linked to parkinson's disease surgeons remove gallbladder through vagina transsexuals can benefit from nose reshaping novel tonsillectomy cuts pain, bleeding back to medications index last editorial review: 8 12 2000 medicinenet provides reliable doctor produced health and medical information. Yet another ACE inhibitor joins an already crowded market. Imidapril is licensed for treatment of hypertension but NOT heart failure ; and is taken once daily. The usual starting dose is 5mg but this can be increased up to 10mg after 3 weeks if necessary. The monthly 28 day ; treatment costs based on usual maintenance dose ; of some of the ACEIs are outlined below Drug Imidapril Captopril Enalapril Lisinopril Quinapril Ramipril Usual maintenance dose 5-10mg daily 25mg BD 10-20mg daily 10-20mg daily 20-40mg daily 2.5-5mg daily Cost 5.92- 6.69 4.06. Titrate up very slowly to minimize somnolence - one of the most common reasons parents dislike discontinue this medication.

The four currently recognised species of the genus Echinococcus Table 1.1. ; which are regarded as valid taxonomically are Echinococcus granulosus Batsch, 1786 ; , Echinococcus multilocularis Leuckart, 1863, Echinococcus oligarthrus Diesing, 1863 ; and Echinococcus vogeli Rausch and Bernstein, 1972 15, 16, ; . These four species are morphologically distinct in both adult and larval stages. Specific morphological characters that are valuable for taxonomic discrimination of the adult stage of each species are indicated in Table 1.1. and Figure 1.6 and diltiazem. Large investment losses are observed among users of antihypertensive drugs, inhalation corticosteroids and antidepressants, and to a lesser degree among users of cholesterol lowering drugs. Table 2. Drugs Commonly Used for Treatment of Chronic Heart Failure Drug Loop diuretics * Bumetanide Furosemide Torsemide ACE inhibitors Captopril Enalapril Fosinopril Lisinopril Quinapril Ramipril Beta-receptor blockers Bisoprolol Carvedilol Metoprolol tartrate Metoprolol succinate extended release + Digitalis glycosides Digoxin Initial Dose 0.5 to 1.0 mg once or twice daily 20 to 40 mg once or twice daily 10 to 20 mg once or twice daily 6.25 mg 3 times daily 2.5 mg twice daily 5 to 10 mg once daily 2.5 to 5.0 mg once daily 10 mg twice daily 1.25 to 2.5 mg once daily 1.25 mg once daily 3.125 mg twice daily 6.25 mg twice daily 12.5 to 25 mg daily 0.125 to 0.25 mg once daily.

Captopril online

The 10 highest-paid executives across the nine companies received a total of 6 million in compensation in 2001, exclusive of unexercised stock options see Table 4 ; . Compensation ranged from a high of nearly million to a "low" of almost million, with the executives receiving, on average, nearly million, exclusive of unexercised stock options. Formation plays a role in the destruction of pancreatic -cells during the development of type I diabetes 2 ; . S-nitrosothiols are adducts of NO and free sulfhydryl SH ; groups, and they are detectable in both blood and tissues 3 ; . In addition, S-nitrosothiol formation may mediate the bioactivity of nitrovasodilator drugs 4 ; . Snitrosoglutathione GSNO ; is a common source of NO in the biomedical field, which has shown great biological diversity. GSNO, a physiological Snitrosothiol compound, possesses potent antiplatelet aggregatory activity despite a slow rate of NO release and modest capacity to stimulate intraplatelet cyclic GMP accumulation. At low concentrations, exogenous GSNO has been shown to provide significant protection to the ischemic myocardium 5 ; . It also used therapeutically as an arterioselective vasodilator 6 ; and antithrombotic agent 7 ; . A recent study conducted in our laboratory showed GSNO to induce a state of impaired glucose tolerance 8 ; . Abnormalities at the level of insulin receptor have been implicated in a number of insulin-resistant states 9 ; . In some disorders of carbohydrate metabolism, changes in insulin receptor affinity alone or in addition to changes in receptor number have been observed 10 ; . The present study was so designed as to investigate the possible effects of GSNO on insulin binding to its receptor on erythrocyte cell membranes in dogs treated with GSNO and controls treated with captopril. Seek emergency medical attention if you develop any of these symptoms while taking captopril.

In elderly patients, systolic BP is the major determinant of outcome, and recent treatment trials have tended to concentrate on patients with isolated systolic hypertension ISH ; . Trials have used all of the 4 major classes of antihypertensive agents as baseline therapy thiazides, -blockers, calcium channel blockers [CCBs], and angiotensin-converting enzyme [ACE] inhibitors ; , but it should be remembered that all trials use multiple drug therapy in most patients. A recent meta-analysis of 8 trials involving patients with ISH has confirmed the quality of the evidence for benefit.1 Overall, there were significant reductions in the incidence of stroke 30% ; , coronary heart disease CHD, 23% ; , all cardiovascular disease CVD, 26% ; , CV mortality 18% ; , and all-cause mortality 13% ; . There can be no debate about the value of such interventions. In elderly hypertensive patients with ISH, international guidelines recommend low-dose thiazide diuretics or long-acting dihydropyridine CCBs as preferred first-line therapy. The HYpertension in the Very Elderly Trial HYVET ; , 2 with 2100 hypertensives aged over 80 years randomized to active treatment with Natrilix SR, a low-dose thiazide-like diuretic, or placebo for 5 years, will help determine whether antihypertensive treatment is beneficial or not in these patients. A "maintenance" drug is one taken for a long period of time and is designated by Medco as a "maintenance" drug. Call Medco Customer Service at 1-800-8413423 to find out if a prescription drug is designated as a "maintenance" drug by Medco. Insulin and syringes used to administer insulin are not categorized as "maintenance" drugs and are not subject to these "maintenance" drug provisions.